Cognitive-Behavioral Therapy May Aid Menopause Outcomes
Medically reviewed by Drugs.com
via HealthDayTHURSDAY, May 14, 2026 -- Cognitive-behavioral therapy (CBT) for menopausal insomnia improves sleep and hot flash interference in postmenopausal women, according to a study published online May 5 in Menopause.
Emily J. Arentson-Lantz, Ph.D., from the University of Texas Medical Branch in Galveston, and colleagues evaluated a CBT intervention for both insomnia and vasomotor symptoms in perimenopausal and postmenopausal women. The analysis included 43 participants with at least one nocturnal hot flash per night and diagnostic criteria for insomnia disorder who were randomly assigned to CBT or menopause education control.
The researchers found that CBT for menopausal insomnia was associated with significantly reduced Insomnia Severity Index scores (ISI; −10.2 versus −6.2 for control), reduced Hot Flash Daily Interference Scale scores (−1.3 versus −0.5), and increased Sleep Self-Efficacy Scale scores (10.2 versus 5.9) posttreatment. Similar results were seen at one month after the end of treatment. For the ISI, CBT significantly decreased nighttime sleep symptoms and patient perception of insomnia posttreatment and at one month versus the control. At three months, nighttime sleep symptoms remained improved versus control.
"The study's findings highlight the utility of cognitive-behavioral therapy as a standalone treatment for insomnia and hot flashes, offering women an alternative or adjunct to pharmacologic treatments," Monica Christmas, M.D., associate medical director for The Menopause Society, said in a statement.
One author disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-05-15 09:45
Read more
- CMS Extends Medicare's Short-Term Bridge Program for GLP-1 Obesity Drug Coverage
- Ifinatamab Deruxtecan Granted Priority Review in the U.S. for Adult Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer who Experienced Disease Progression on or After Platinum-Based Chemotherapy
- ACP: Muscle-Related Loss Often Exceeds Benchmarks With Incretin-Based Therapies
- Sigmoidoscopy Screening Can Reduce Colorectal Cancer Incidence, Death
- Cognitive-Behavioral Therapy + Meds Recommended Over Meds Alone for Insomnia
- Daylight Saving Time Fails to Boost Daily Steps, Study Finds
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions